GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CG Oncology, Inc. (CGON) | 11/6/2026 8:51:49 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $1,604,000 -3.7% | Assets $1,046,670,000 | EPS -$0.64 | |
| CG Oncology, Inc. (CGON) | 11/6/2026 8:31:35 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $1,604,000 -3.7% | Assets $1,046,670,000 | EPS -$0.64 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 8/6/2026 8:52:10 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $1,157,000 | Assets $1,085,655,000 | EPS -$0.90 | |
| CG Oncology, Inc. (CGON) | 8/6/2026 8:31:16 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,157,000 | Assets $1,085,655,000 | EPS -$0.90 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 5/8/2026 4:25:02 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,083,000 +1,982.7% | Assets $1,135,262,000 | EPS -$0.71 | |
| CG Oncology, Inc. (CGON) | 5/8/2026 8:46:17 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,083,000 +1,982.7% | Assets $1,135,262,000 | EPS -$0.71 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 4/24/2026 4:38:31 PM | View | Proxy | SEC | Y 2025 | ||||||
| CG Oncology, Inc. (CGON) | 2/27/2026 9:16:33 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $4,040,000 +254.7% | Assets $791,592,000 | EPS -$2.08 | |
| CG Oncology, Inc. (CGON) | 2/27/2026 8:46:10 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $2,322,000 +409.2% | Assets $791,592,000 | EPS -$0.51 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 11/14/2025 4:35:13 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,666,000 +3,774.4% | Assets $729,913,000 | EPS -$0.57 | |
| CG Oncology, Inc. (CGON) | 11/14/2025 8:17:24 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,666,000 +3,774.4% | Assets $729,913,000 | EPS -$0.57 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 8/8/2025 4:22:20 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $701,445,000 | EPS -$0.54 | ||
| CG Oncology, Inc. (CGON) | 8/8/2025 8:16:48 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $0 | Assets $701,445,000 | EPS -$0.54 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 5/13/2025 8:41:49 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $52,000 -90.2% | Assets $728,181,000 | EPS -$0.45 | |
| CG Oncology, Inc. (CGON) | 5/13/2025 8:16:06 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $52,000 -90.2% | Assets $728,181,000 | EPS -$0.45 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 4/25/2025 8:07:20 AM | View | Proxy | SEC | Y 2024 | ||||||
| CG Oncology, Inc. (CGON) | 3/28/2025 9:06:32 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $1,139,000 +458.3% | Assets $754,797,000 | EPS -$1.41 | |
| CG Oncology, Inc. (CGON) | 3/28/2025 7:16:46 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $456,000 +45,500.0% | Assets $754,797,000 | EPS -$0.48 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 11/12/2024 9:43:40 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $43,000 +377.8% | Assets $552,471,000 | EPS -$0.30 | |
| CG Oncology, Inc. (CGON) | 11/12/2024 9:31:41 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $43,000 +377.8% | Assets $552,471,000 | EPS -$0.30 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 8/8/2024 6:38:24 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $111,000 | Assets $564,330,000 | EPS -$0.28 | |
| CG Oncology, Inc. (CGON) | 8/8/2024 6:20:00 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $111,000 | Assets $564,330,000 | EPS -$0.28 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 5/9/2024 8:12:27 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $529,000 +172.7% | Assets $579,108,000 | EPS -$0.36 | Export Earnings Model | |
| CG Oncology, Inc. (CGON) | 5/9/2024 6:18:01 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $529,000 +172.7% | Assets $579,108,000 | EPS -$0.36 |